Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients.
Gafter-Gvili, Anat; Fraser, Abigail; Paul, Mical; Leibovici, Leonard.
Ann Intern Med
; 142(12 Pt 1): 979-95, 2005 Jun 21.
Artigo em Inglês | MEDLINE | ID: mdl-15968013
Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
Moxifloxacin is more effective than tosufloxacin in reducing chemotherapy-induced febrile neutropenia in patients with hematological malignancies.
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia.
Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia.
Impact of fluoroquinolone prophylaxis during neutropenia on bloodstream infection: Data from a surveillance program in 8755 patients receiving high-dose chemotherapy for haematologic malignancies between 2009 and 2014.
Use of antibacterial prophylaxis for patients with neutropenia. Australian Consensus Guidelines 2011 Steering Committee.
Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
Venetoclax: A novel B-cell lymphoma-2 inhibitor for chronic lymphocytic leukemia and other hematologic malignancies.
Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
A comparison of levofloxacin and oral third-generation cephalosporins as antibacterial prophylaxis in acute leukaemia patients during chemotherapy-induced neutropenia.